Trastuzumab duocarmazine
Trastuzumab duocarmazine Uses, Dosage, Side Effects, Food Interaction and all others data.
Trastuzumab duocarmazine is under investigation in clinical trial NCT03262935 (SYD985 vs. Physician's Choice in Participants With Her2-positive Locally Advanced or Metastatic Breast Cancer).
| Trade Name | Trastuzumab duocarmazine |
| Generic | Trastuzumab duocarmazine |
| Trastuzumab duocarmazine Other Names | Immunoglobulin g1-kappa, anti-(homo sapiens erbb2 (epidermal growth factor receptor 2, receptor tyrosineprotein kinase erbb-2, egfr2, her2, her-2, p185cerbb2, neu, cd340)), humanized monoclonal antibody conjugated to the pro-drug seco-duocarmycinhydroxyb, Trastuzumab duocarmazine |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Trastuzumab duocarmazine
